Detalhe da pesquisa
1.
Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
J Thorac Oncol
; 19(6): 928-940, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278303
2.
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Clin Lung Cancer
; 24(8): 689-695.e1, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880074
3.
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
Cancer Treat Res Commun
; 36: 100743, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531736
4.
Sex Differences in All-Cause Inpatient Mortality Risk in Gastric Cancer: Nationwide Inpatient Population-Based Study.
Cureus
; 14(8): e28602, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185836